FDA Flags 12 Companies for Illicit Hydroquinone-containing Skin Brighteners

April 21, 2022

The U.S. Food and Drug Administration (FDA) has issued warning letters to 12 companies for selling illicit skin brighteners. The products contain the active drug hydroquinone, rendering them unapproved over-the-counter (OTC) drugs rather than cosmetics—and they do not meet the requirements to be legally sold as OTC drugs.The warning letters highlight that these OTC skin-brightening products are not generally recognized as safe or effective (i.e., not GRASE). In fact, the FDA has received reports of serious side effects including skin rashes, facial swelling and ochronosis (discoloration of skin) from the use of skin-brightening products containing hydroquinone. The FDA advises consumers to not use these products due to the potential harm they could cause.Notably, some manufacturers and distributors have already removed their OTC skin-brightening products from the market; the FDA plans to take action against those continuing to market these potentially harmful and illegal OTC products.Read more at MedEsthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical
    • Botox Cosmetic’s “The Confidence Collective” to Empower 250 Women Entrepreneurs
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement